Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables.
Diagnosis
Optical coherence tomography
Progression
Progressive supranuclear palsy
Retina
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
18
02
2022
accepted:
03
04
2022
pubmed:
13
4
2022
medline:
6
8
2022
entrez:
12
4
2022
Statut:
ppublish
Résumé
Available evidence reports conflicting data on retinal thickness in progressive supranuclear palsy (PSP). In studies including healthy controls, PSP showed either the thinning of the retinal nerve fiber layer, macular ganglion cell, inner nuclear, or outer retina layer. The goals of the present study were to describe retinal layer thickness in a large cohort of PSP compared to healthy controls and in PSP phenotypes using spectral-domain optical coherence tomography (SD-OCT). The additional objective was to verify the relationship between retinal layers thickness and clinical variables in PSP. Using a cross-sectional design, we examined retinal structure in 27 PSP patients and 27 controls using standard SD-OCT. Motor and cognitive impairment in PSP was rated with the PSP rating scale and the Montreal Cognitive Assessment battery (MoCA), respectively. Eyes with poor image quality or confounding diseases were excluded. SD-OCT measures of PSP and controls were compared with parametric testing, and correlations between retinal layer thicknesses and disease severity were evaluated. PSP showed significant thinning of the inner retinal layer (IRL), ganglion cell layer (GCL), inner plexiform layer (IPL), and the outer plexiform layer (OPL) compared to healthy controls. PSP phenotypes showed similar retinal layer thicknesses. Retinal layer thickness correlated with MoCA visuospatial subscore (p < 0.001). We demonstrated PSP patients disclosed thinner IRL, GCL, IPL, and OPL compared to healthy controls. Furthermore, we found a significant correlation between visuospatial abilities and retinal layers suggesting the existence of a mutual relationship between posterior cognitive function and retinal structure.
Sections du résumé
BACKGROUND
BACKGROUND
Available evidence reports conflicting data on retinal thickness in progressive supranuclear palsy (PSP). In studies including healthy controls, PSP showed either the thinning of the retinal nerve fiber layer, macular ganglion cell, inner nuclear, or outer retina layer.
OBJECTIVES
OBJECTIVE
The goals of the present study were to describe retinal layer thickness in a large cohort of PSP compared to healthy controls and in PSP phenotypes using spectral-domain optical coherence tomography (SD-OCT). The additional objective was to verify the relationship between retinal layers thickness and clinical variables in PSP.
METHODS
METHODS
Using a cross-sectional design, we examined retinal structure in 27 PSP patients and 27 controls using standard SD-OCT. Motor and cognitive impairment in PSP was rated with the PSP rating scale and the Montreal Cognitive Assessment battery (MoCA), respectively. Eyes with poor image quality or confounding diseases were excluded. SD-OCT measures of PSP and controls were compared with parametric testing, and correlations between retinal layer thicknesses and disease severity were evaluated.
RESULTS
RESULTS
PSP showed significant thinning of the inner retinal layer (IRL), ganglion cell layer (GCL), inner plexiform layer (IPL), and the outer plexiform layer (OPL) compared to healthy controls. PSP phenotypes showed similar retinal layer thicknesses. Retinal layer thickness correlated with MoCA visuospatial subscore (p < 0.001).
CONCLUSIONS
CONCLUSIONS
We demonstrated PSP patients disclosed thinner IRL, GCL, IPL, and OPL compared to healthy controls. Furthermore, we found a significant correlation between visuospatial abilities and retinal layers suggesting the existence of a mutual relationship between posterior cognitive function and retinal structure.
Identifiants
pubmed: 35411501
doi: 10.1007/s10072-022-06061-4
pii: 10.1007/s10072-022-06061-4
pmc: PMC9349141
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4803-4809Subventions
Organisme : university of salerno
ID : FARB2019
Informations de copyright
© 2022. The Author(s).
Références
Hoglinger GH, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria. Mov Disord 32:853–864
doi: 10.1002/mds.26987
Picillo M, Tepedino MF, Abate F et al (2020) Midbrain MRI assessments in progressive supranuclear palsy subtypes. J Neurol Neurosurg Psychiatry 91(1):98–103
doi: 10.1136/jnnp-2019-321354
Picillo M, Erro R, Cuoco S, PSP Salerno Study Group et al (2018) MDS PSP criteria in real-life clinical setting: motor and cognitive characterization of subtypes. Mov Disord 33(8):1361–1365
doi: 10.1002/mds.27408
Picillo M, Cuoco S, Tepedino MF et al (2019) Motor, cognitive and behavioral differences in MDS PSP phenotypes. J Neurol 266(7):1727–1735
doi: 10.1007/s00415-019-09324-x
Picillo M, Cuoco S, Carotenuto I et al (2019) Clinical use of SAND battery to evaluate language in patients with progressive supranuclear palsy. PLoS One 14(10):e0223621
doi: 10.1371/journal.pone.0223621
Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Report of the NINDS-SPSP International Workshop. Neurology 47:1–9
doi: 10.1212/WNL.47.1.1
Schon C, Hoffman NA, Ochs SM et al (2012) Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. Plos One 7(12):e53547
doi: 10.1371/journal.pone.0053547
Löffler KU, Edward DP, Tso MO (1995) Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest Ophthalmol Vis Sci 36:24–31
pubmed: 7822152
Leger F, Fernagut PO, Canron MH et al (2011) Protein aggregation in the aging retina. J Neuropathol Exp Neurol 70:63–68
doi: 10.1097/NEN.0b013e31820376cc
Kim BJ, Irwin DJ, Song D et al (2017) Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration. Neurology 89:1604–1611
doi: 10.1212/WNL.0000000000004500
Stemplewitz B, Kromer R, Vettorazzi E et al (2017) Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry. Sci Rep 7:5357
doi: 10.1038/s41598-017-05575-8
Gulmez Sevim D, Unlu M, Gultekin M et al (2018) Evaluation of retinal changes in progressive supranuclear palsy and Parkinson disease. J Neuroophtalmol 38(2):151–155
doi: 10.1097/WNO.0000000000000591
Kim BJ, Grossman M, Song D et al (2019) Persistent and progressive outer retina thinning in frontotemporal degeneration. Front Neurosci 13:298
doi: 10.3389/fnins.2019.00298
Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130(Pt 6):1552–1565
doi: 10.1093/brain/awm032
Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M (2018) Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. J Neurol 265(11):2602–2613
doi: 10.1007/s00415-018-9038-x
Albrecht P, Müller AK, Südmeyer M et al (2012) Optical coherence tomography in parkinsonian syndromes. PLoS One 7(4):e34891
doi: 10.1371/journal.pone.0034891
Schneider M, Müller HP, Lauda F et al (2014) Retinal single-layer analysis in parkinsonian syndromes: an optical coherence tomography study. J Neural Transm (Vienna) 121(1):41–47
doi: 10.1007/s00702-013-1072-3
Woo KA, Shin JY, Kim H et al (2021) Peripapillary retinal fiber layer thinning in patients with progressive supranuclear palsy. J Neurol. https://doi.org/10.1007/s00415-02110936-5 .
Coppola G, Di Renzo A, Ziccardi L et al (2015) Optical coherence tomography in Alzheimer’s disease: a meta-analysis. Plos One 10:e0134750
doi: 10.1371/journal.pone.0134750
Cheung CY, Chan VTT, Mok VC, Chen C, Wong TY (2019) Potential retinal biomarkers for dementia: what is new? Curr Opin Neurol 32:82–91
doi: 10.1097/WCO.0000000000000645
De Bernardo M, Salerno G, Gioia M et al (2021) Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson’s disease. Sci Rep 11(1):8936
doi: 10.1038/s41598-021-88250-3
De Bernardo M, Salerno G, Cornetta P, Rosa N (2018) Axial length shortening after cataract surgery: new approach to solve the question. Transl Vis Sci Technol 7(6):34
doi: 10.1167/tvst.7.6.34
Jakimoski D, Benedict RHB, Weinstock-Guttman B et al (2021) Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate or both? J Neurol 268(7):2578–2588
doi: 10.1007/s00415-021-10437-5
Armstrong R, Kergoat H (2015) Oculovisual changes and clinical considerations affecting older patients with dementia. Ophthalmic Physiol Opt 35(4):352–376
doi: 10.1111/opo.12220
Pietroboni AM, Dell’Arti L, Caprioli M et al (2019) The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler 25(1):31–38
doi: 10.1177/1352458517740214